Gene therapy programs
Regenxbio develops gene medicines that are meant to give patients a working copy of a gene or help the body make a needed protein. The company focuses on therapies for rare and serious diseases and runs the research, tes...
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Regenxbio is a biotechnology company that develops gene therapy medicines. It works by designing viral vectors that can deliver working genes into a patient’s cells, mainly for rare and serious diseases. The company’s business is built around research, clinical development, and licensing its gene therapy technology to drug makers that want to use it in their own programs.
The company does not sell consumer products. Its main customers are pharmaceutical and biotech partners, as well as the healthcare system that ultimately uses the medicines it helps create. Regenxbio makes money through collaboration payments, licensing fees, milestone payments, and royalties tied to partnered products, along with potential sales revenue if any of its own therapies reach the market.
What makes Regenxbio different is its role as both a drug developer and a technology supplier. Instead of only betting on one medicine, it also earns from a platform that can be used across many gene therapy programs. That gives it exposure to the broader gene therapy market while keeping its focus on diseases where a one-time genetic treatment could be a better fit than long-term drug use.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
New to Alpha Spread? Create free account
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Already have an account? Sign in
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more